Nanfang-Chunfu Children's Institute of Hematology and Oncology

Nanfang-Chunfu Children's Institute of Hematology and Oncology is a specialized medical and research institution based in Guangzhou, China, dedicated to pediatric blood disorders and cancers. Founded by the prominent hematologist Dr. Li Chunfu, the institute is a global leader in hematopoietic stem cell transplantation (HSCT), particularly for the treatment of thalassemia and high-risk leukemia. It is renowned for developing the NF-08-TM protocol, which has significantly improved the success rates of haploidentical transplants in children. The institute operates as a high-volume clinical center, integrating advanced cell therapies and personalized medicine to treat complex hematological conditions. By providing innovative curative options for patients who lack fully matched donors, it has become a key destination for pediatric hematology in Asia.